Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
Cielo García‐Montero, Óscar Fraile-Martínez, Coral Bravo, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 433-433
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review
Ibrahim Mohammed, Areej Nauman, Pradipta Paul, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 281
Review of COVID-19 vaccine subtypes, efficacy and geographical distributions
Andre Ian Francis, Saudah Ghany, Tia Gilkes, et al.
Postgraduate Medical Journal (2021) Vol. 98, Iss. 1159, pp. 389-394
Open Access | Times Cited: 205
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 4-14
Open Access | Times Cited: 199
Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2
Mina Psichοgiou, Michael Samarkos, Nikolaos Mikos, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 572-572
Open Access | Times Cited: 125
Knowledge and Acceptance of COVID-19 Vaccination among Undergraduate Students from Central and Southern Italy
Francesca Gallè, Elita Anna Sabella, Paolo Roma, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 638-638
Open Access | Times Cited: 122
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 81
COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 75
Acceptance of COVID-19 Vaccination in the Elderly: A Cross-Sectional Study in Southern Italy
Francesca Gallè, Elita Anna Sabella, Paolo Roma, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1222-1222
Open Access | Times Cited: 89
Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination
Samy Hakroush, Björn Tampe
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 84
Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination
Haya Altawalah
Vaccines (2021) Vol. 9, Iss. 8, pp. 910-910
Open Access | Times Cited: 69
Systemic lupus erythematosus and antiphospholipid syndrome after COVID-19 vaccination. A case report
Sebastián Molina-Ríos, Rigoberto Rojas-Martinez, Gloria Marcela Estévez-Ramirez, et al.
Modern Rheumatology Case Reports (2022) Vol. 7, Iss. 1, pp. 43-46
Open Access | Times Cited: 40
Omicron-specific mRNA vaccine induced potent neutralizing antibody against Omicron but not other SARS-CoV-2 variants
I-Jung Lee, Cheng‐Pu Sun, Ping‐Yi Wu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 37
Reported side-effects following Oxford/AstraZeneca COVID-19 vaccine in the north-west province, Iran: A cross-sectional study
Majid Eterafi, Nasrin Fouladi, Majid Golizadeh, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0296669-e0296669
Open Access | Times Cited: 9
Egypt's COVID-19 Recent Happenings and Perspectives: A Mini-Review
AbdulRahman A. Saied, Asmaa A. Metwally, Norah Madkhali, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 54
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 49
Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis
Michele Gringeri, Vera Battini, Gianluca Cammarata, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 5, pp. 675-684
Closed Access | Times Cited: 33
Qingjin Yiqi granules for post‐COVID‐19 condition: A randomized clinical trial
Wentai Pang, Fengwen Yang, Yubin Zhao, et al.
Journal of Evidence-Based Medicine (2022) Vol. 15, Iss. 1, pp. 30-38
Open Access | Times Cited: 30
Biochemical Screening of Phytochemicals and Identification of Scopoletin as a Potential Inhibitor of SARS-CoV-2 Mpro, Revealing Its Biophysical Impact on Structural Stability
Sarika Bano, Jyotishna Singh, Zainy Zehra, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 402-402
Open Access
Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals
Jéromine Klingler, Gregory S. Lambert, Vincenza Itri, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 35
A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens
Shobha Upreti, Mukesh Samant
Pharmaceutical Research (2022) Vol. 39, Iss. 9, pp. 2119-2134
Open Access | Times Cited: 24
Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2
Marlene Plüß, Kemal Mese, Johannes T. Kowallick, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 23
Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article
AbdulRahman A. Saied, Asmaa A. Metwally, Moses Alobo, et al.
International Journal of Surgery (2022) Vol. 98, pp. 106233-106233
Open Access | Times Cited: 23
Durability of immune responses to SARS-CoV-2 infection and vaccination
Mehul S. Suthar
Seminars in Immunology (2024) Vol. 73, pp. 101884-101884
Closed Access | Times Cited: 4
Effectiveness of COVID‑19 vaccines and their challenges (Review)
Gabriella Marfè, Stefania Perna, Arvind Shukla
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 30
Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences
Dorota Kamińska, Dominika Dęborska−Materkowska, Katarzyna Kościelska−Kasprzak, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1068-1068
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top